Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Screening Strategies for BRCA Mutation Carriers

Current Screening Recommendations

  • The European Society for Medical Oncology (ESMO) guidelines support alternating mammography and MRI at 6-month intervals as an effective screening strategy for BRCA mutation carriers to maximize early cancer detection 1
  • Annual breast MRI is recommended from age 25, with the addition of annual mammography from age 30, according to the American College of Radiology and the Society of Breast Imaging 2
  • Clinical breast examination every 6-12 months is recommended starting from age 25 or 10 years before the youngest breast cancer diagnosis in the family, whichever is earlier, as suggested by the National Comprehensive Cancer Network 2

Evidence Supporting 6-Month Interval Screening

  • The ESMO guidelines specifically state that annual MRI can be performed "concomitantly or alternating every 6 months with mammography" for women with familial breast cancer or BRCA mutations 1

Practical Implementation of 6-Month Interval Screening

  • Begin MRI screening at age 25 for all BRCA mutation carriers, as recommended by the American College of Obstetricians and Gynecologists 2
  • Schedule MRI and mammography approximately 6 months apart to provide more frequent surveillance throughout the year, according to the European Society for Medical Oncology 1
  • Continue clinical breast examinations every 6-12 months regardless of imaging schedule, as suggested by the National Comprehensive Cancer Network 2